In early drug development, what is the main purpose of consulting an advisory board?

In early drug development, what is the main purpose of consulting an advisory board?

• A. To approve the trial protocol
• B. To provide their opinion on the research and development of the drug
• C. To market the drug
• D. To set pricing

Answer: (B)

The main idea is to gain independent expert input to shape the drug’s development. In early development, an advisory board is brought in to offer their expert opinions on how the research and development plan should proceed. They review aspects like trial design, choice of endpoints, patient populations, and potential safety and feasibility issues. This external perspective helps the sponsor refine the protocol, anticipate challenges, and make informed go/no-go decisions, aligning the plan with scientific rigor and regulatory expectations. They’re not responsible for approving the protocol, marketing the drug, or setting pricing—their role is to contribute insightful scientific and clinical guidance that informs development decisions and strategy.

The main idea is to gain independent expert input to shape the drug’s development. In early development, an advisory board is brought in to offer their expert opinions on how the research and development plan should proceed. They review aspects like trial design, choice of endpoints, patient populations, and potential safety and feasibility issues. This external perspective helps the sponsor refine the protocol, anticipate challenges, and make informed go/no-go decisions, aligning the plan with scientific rigor and regulatory expectations. They’re not responsible for approving the protocol, marketing the drug, or setting pricing—their role is to contribute insightful scientific and clinical guidance that informs development decisions and strategy.